Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for CLPBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 -13.71%
December 31, 2025 19.84%
September 30, 2025 12.57%
June 30, 2025 11.57%
March 31, 2025 13.16%
December 31, 2024 14.86%
September 30, 2024 18.90%
June 30, 2024 18.50%
March 31, 2024 19.01%
December 31, 2023 18.35%
September 30, 2023 19.74%
June 30, 2023 20.83%
March 31, 2023 19.06%
December 31, 2022 18.46%
September 30, 2022 20.30%
June 30, 2022 22.04%
March 31, 2022 17.81%
December 31, 2021 23.35%
September 30, 2021 25.59%
June 30, 2021 25.94%
March 31, 2021 23.77%
December 31, 2020 23.98%
September 30, 2020 22.68%
June 30, 2020 22.56%
March 31, 2020 22.12%
Date Value
December 31, 2019 23.17%
September 30, 2019 17.17%
June 30, 2019 23.22%
March 31, 2019 23.20%
December 31, 2018 22.93%
September 30, 2018 24.54%
June 30, 2018 22.44%
March 31, 2018 22.75%
December 31, 2017 23.77%
September 30, 2017 25.38%
June 30, 2017 23.26%
March 31, 2017 23.99%
December 31, 2016 25.19%
September 30, 2016 11.34%
June 30, 2016 26.53%
March 31, 2016 25.44%
December 31, 2015 22.57%
September 30, 2015 -39.27%
June 30, 2015 20.03%
March 31, 2015 23.64%
December 31, 2014 24.14%
September 30, 2014 26.17%
June 30, 2014 25.14%
March 31, 2014 -0.63%
December 31, 2013 25.47%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Ambu A/S 7.69%
Abbott Laboratories 9.65%
AngioDynamics, Inc. -10.31%
Alphatec Holdings, Inc. -17.65%
AtriCure, Inc. 0.08%